Mipyrin (Paracetamol, Acetylsalicylic Acid, Caffeine)

Paracetamol reduces pain by centrally inhibiting COX enzymes and lowering prostaglandin synthesis. Acetylsalicylic acid irreversibly blocks COX‑1 and COX‑2, decreasing peripheral prostaglandin production. Caffeine antagonises adenosine receptors, which enhances the analgesic action of the other two agents and speeds up symptom relief.

The appropriate dose of Mipyrin is determined by the prescribing healthcare professional based on the individual’s age, condition and response. Patients should follow the prescriber’s instructions and not exceed the recommended amount indicated on the product label.

Safety of Mipyrin in pregnancy or while breastfeeding has not been fully established. Women who are pregnant, planning pregnancy or nursing should consult their physician before using this product to weigh potential benefits against possible risks.

To order Mipyrin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mipyrin combines three active ingredients, offering a broader mechanism of action than single‑component analgesics such as paracetamol alone. The addition of aspirin provides anti‑inflammatory benefits, while caffeine enhances pain relief speed. This multi‑component profile can be more effective for certain headaches or migraines compared with monotherapy, though individual response varies.

Mipyrin should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Mipyrin is taken orally with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless directed otherwise by a healthcare professional. It is intended for use by adults and should be taken as prescribed.

Serious risks include gastrointestinal bleeding, severe allergic reactions such as anaphylaxis, and potential liver toxicity, especially when taken in excess or combined with other hepatotoxic substances. Patients should seek immediate medical attention if they notice signs of bleeding, rash, swelling, or jaundice.

Mipyrin should be avoided by individuals with known hypersensitivity to aspirin, paracetamol, caffeine or any component of the formulation. It is also contraindicated in patients with active peptic ulcer disease, severe liver impairment, or in children with viral infections due to the risk of Reye's syndrome.